SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001213900-22-063371
Filing Date
2022-10-12
Accepted
2022-10-11 20:04:27
Documents
9

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea167011-s1_inmedpharma.htm S-1 464708
2 OPINION OF NORTON ROSE FULBRIGHT CANADA LLP ea167011ex5-1_inmedpharma.htm EX-5.1 18607
3 CONSENT OF KPMG LLP ea167011ex23-1_inmedpharma.htm EX-23.1 3050
4 FILING FEE TABLE ea167011ex-fee_inmedpharma.htm EX-FILING FEES 17795
5 GRAPHIC image_001.jpg GRAPHIC 5637
6 GRAPHIC image_002.jpg GRAPHIC 26777
7 GRAPHIC image_003.jpg GRAPHIC 5637
8 GRAPHIC ex5-1_001.jpg GRAPHIC 14045
9 GRAPHIC ex5-1_002.jpg GRAPHIC 2955
  Complete submission text file 0001213900-22-063371.txt   581657
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: S-1 | Act: 33 | File No.: 333-267831 | Film No.: 221305231
SIC: 2834 Pharmaceutical Preparations